Epidermolysis bullosa (EB) is a group of inherited bullous disorders characterized by blister formation in response to mechanical trauma. Recent discoveries of the molecular basis of epidermolysis bullosa have resulted in the development of new diagnostic tools, including prenatal and preimplantation testing. Epidermolysis bullosa is classified into 3 major categories, including: (1) epidermolysis bullosa simplex (intraepidermal skin separation) (2) junctional epidermolysis bullosa (skin separation in lamina lucida or central BMZ) and (3) dystrophic epidermolysis bullosa (sublamina densa BMZ separation It is an inherited disease that causes painful fluid filled blisters to form on the skin.There is no cure for this disease.It mostly affects the children
• Difficulty in swallowing
The diagnosis is done by performing a biopsy and physical examination. Routine histologic analysis is useful only for excluding other causes of blistering.The evaluation of Gene therapy for non-lethal junctional epidermolysis bullosa has been performed and shown to be efficacious in a small trial of one patient. In gene therapy, the goal is to deliver genes targeted to restore normal protein production. anemia using CBC count with iron studies in patients with severe epidermolysis bullosa, especially recessively inherited epidermolysis bullosa. There is no proper cure for this disease.
The mild cases of epidermolysis bullosa simplex are reported only 10% of the time, the affected population in the Ireland is approximately 12,500 persons. Of these cases, approximately 92% are epidermolysis bullosa simplex, 5% are dystrophic epidermolysis bullosa, 1% are junctional epidermolysis bullosa, and 2% are unclassified. nfancy is an especially difficult time for epidermolysis bullosa patients. Generalized blistering caused by any subtype may be complicated by infection, sepsis, and death. Severe forms of epidermolysis bullosa increase the mortality risk during infancy.